Ji In Park
Overview
Explore the profile of Ji In Park including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
68
Citations
468
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Park J, Kim M, Lee K, Oh S, Kang Y, Kim H
Plants (Basel)
. 2024 Dec;
13(23).
PMID: 39683194
A vision transformer (ViT)-based deep neural network was applied to classify the flavonoid glycoside isomers by analyzing electrospray ionization tandem mass spectrometry (ESI-MS/MS) spectra. Our model successfully classified the flavonoid...
2.
Han J, Han J, Ko J, Jung J, Park J, Hwang J, et al.
Sci Rep
. 2024 Nov;
14(1):28253.
PMID: 39548212
Age-related macular degeneration (AMD) is a major cause of blindness in developed countries, and the number of affected patients is increasing worldwide. Intravitreal injections of anti-vascular endothelial growth factor (VEGF)...
3.
Jeong J, Lee Y, Lee S, Baek H, Choi M, Her Y, et al.
J Korean Med Sci
. 2024 Nov;
39(43):e280.
PMID: 39536789
Background: Cutaneous manifestations are frequently observed in end-stage kidney disease (ESKD) and affect the quality of life (QoL) of patients undergoing maintenance hemodialysis (HD). Even patients undergoing HD who frequently...
4.
Kang C, Han J, Son S, Lee S, Baek H, Hwang D, et al.
Sci Rep
. 2024 Nov;
14(1):26739.
PMID: 39500941
Patients with end-stage kidney disease (ESKD) frequently experience anemia, and maintaining hemoglobin (Hb) levels within a targeted range using erythropoiesis-stimulating agents (ESAs) is challenging. This study introduces a gated recurrent...
5.
Park S, Kim Y, Baek C, Cho H, Park J, Koh E, et al.
Kidney Res Clin Pract
. 2024 Oct;
PMID: 39384361
Background: Immunoglobulin A nephropathy (IgAN) is a major cause of end-stage kidney disease (ESKD). The International IgA Nephropathy Prediction Tool (IIgAN-PT) predicts IgAN prognosis, but improvement in the prediction performance...
6.
Park S, Kim J, Yu U, Park J
Int J Clin Pharmacol Ther
. 2024 Sep;
62(12):560-568.
PMID: 39315482
Objective: Previous findings on predictors of vancomycin-induced acute kidney injury (AKI) are inconsistent. We aimed to identify the predictors of vancomycin-induced AKI using the Observational Medical Outcome Partnership Common Data...
7.
In reply: evaluating the efficacy of PENG and SIFICB in hip fracture analgesia - a critical analysis
Koh W, Kim H, Kim Y, Park J, Yeo H, Ro Y, et al.
Reg Anesth Pain Med
. 2024 Sep;
PMID: 39288957
No abstract available.
8.
Lee J, Kim H, Lim M, Kim C, La Y, Jeon Y, et al.
Sci Rep
. 2024 Sep;
14(1):20651.
PMID: 39232049
Severe fever with thrombocytopenia syndrome (SFTS) is a tick-borne illness with a notable morality risk that is becoming increasingly prevalent in East Asia (14-36%). Increasing evidence indicates a more direct...
9.
Park M, Son S, Lee S, Baek H, Park J
Cyberpsychol Behav Soc Netw
. 2024 Aug;
27(12):939-947.
PMID: 39133128
This study examines digital health challenges among end-stage kidney disease (ESKD) patients, a population characterized by older age, lower socioeconomic status, and limited access to modern technologies. Drawing from the...
10.
Park S, Yu U, Oh W, Ryu S, Son S, Lee S, et al.
Medicine (Baltimore)
. 2024 Aug;
103(32):e39202.
PMID: 39121317
Vancomycin, a first-line drug for treating methicillin-resistant Staphylococcus aureus infections, is associated with acute kidney injury (AKI). This study involved an evaluation of biomarkers for AKI detection and their comparison...